Biologicals, Год журнала: 2025, Номер 91, С. 101841 - 101841
Опубликована: Май 8, 2025
Язык: Английский
Small Structures, Год журнала: 2025, Номер unknown
Опубликована: Фев. 19, 2025
To effectively address crisis emergence of new virus such as monkeypox, a collective and collaborative effort between scientists, engineers, innovators, artists from all ages, regions, diverse fields is required. This review explores holistic approach to addressing the monkeypox by integrating nanobiosensors, artificial intelligence, visual arts, humanities, social sciences. Traditional diagnostic methods are often limited time, accessibility, accuracy, but advancement point‐of‐care smart nanobiosensors offers promising shift toward rapid, precise, accessible diagnostics. They enhance ability screen, diagnose, monitor infections efficiently, contributing better disease management. Beyond technological innovation, essential role sciences in fostering public engagement, understanding, acceptance tools emphasized. Visual arts can illustrate scientific concepts, making them more relatable, while storytelling through various media reduce stigma promote preventive measures. Social provide insights into cultural attitudes, behaviors, health challenges, ensuring that solutions integrated communities. By combining these disciplines, this presents comprehensive framework for resilient global system aligns with One Health principles, emphasizing interconnectedness human, animal, environmental health.
Язык: Английский
Процитировано
1
Viruses, Год журнала: 2024, Номер 16(10), С. 1578 - 1578
Опубликована: Окт. 8, 2024
The Africa Centers for Disease Control and Prevention declared mpox a Public Health Emergency of Continental Security (PHECS) in Africa. African public health systems have moved to mobilize response against backdrop inherent significant challenges. With this commentary, we discuss how lessons from past emergencies, particularly COVID-19 Ebola outbreaks, prepared the region improved disease surveillance, rapid strategies, effective communication these can be applied response, emphasizing importance strong healthcare infrastructure, data sharing, community engagement, targeted interventions, robust contact tracing. Additionally, addressing misinformation building trust are crucial controlling spread any disease. By leveraging countries enhance their mpox. This includes improving diagnostic capabilities, strengthening cross-border collaborations, prioritizing vaccination campaigns where needed. Ultimately, by applying hard-earned pandemic outbreak, East better address challenges posed safeguard health.
Язык: Английский
Процитировано
5
Health Science Reports, Год журнала: 2025, Номер 8(4)
Опубликована: Апрель 1, 2025
ABSTRACT Background and Aims The mpox virus, sometimes known as MPXV, is the cause of disease mpox. Monkeypox virus a different Poxviridae family member from orthopoxvirus (OPXV) group. Clades I II are two varieties virus. can spread person to through direct contact with infectious skin or other lesions, such those on mouth genitalia. animal people by bites scratches, well tasks including skinning, trapping, cooking, playing carcasses, eating animals. People compromised immune systems, small children, history eczema, pregnant women may be more susceptible serious illness. This review aimed identify challenges mpox, treatment alternatives, prevention modalities. Methods addressed etiology, epidemiology, risk factors, clinical presentations, evaluation techniques, currently available treatments, preventative measures. An analysis narrative data was conducted instead pooled analysis. Complete published in English included comprehensive literature search across relevant databases pertaining Results recommended laboratory test for polymerase chain reaction detection viral DNA. It crucial differentiate measles, scabies, herpes, syphilis, chickenpox, bacterial infections, allergies related medications ability distinguish between chickenpox made lymphadenopathy. JYNNEOS vaccine, ACAM2000 MVABN also Imvamune vaccinations have now been investigated authorized usage during epidemics locations. Tecovirimat, brincidofovir, cidofovir which had previously shown promise against OPXV were used antivirals 2022 outbreak. Conclusion provides brief overview current antiviral that assessed their potential treatments since threat came into existence will provided. useful increase awareness recognize common manifestations diagnose, its methods. To effectively reduce global transmission WHO should prioritize strategies enhance early illness, careful administration focused vaccination initiatives high‐risk groups wider immunization areas where common. Furthermore, it establish preventive measures, conduct educational outreach, implement robust healthcare policies.
Язык: Английский
Процитировано
0
Micromachines, Год журнала: 2025, Номер 16(4), С. 472 - 472
Опубликована: Апрель 15, 2025
Frequent outbreaks of respiratory infectious diseases, driven by diverse pathogens, have long posed significant threats to public health, economic productivity, and societal stability. Respiratory diseases are highly contagious, characterized short incubation periods, symptoms, multiple transmission routes, susceptibility mutations, distinct seasonality, contributing their propensity for outbreaks. The absence effective antiviral treatments the heightened vulnerability individuals with weakened immune systems make them more susceptible infection, severe cases potentially leading complications or death. This situation becomes particularly concerning during peak seasons, such as influenza Therefore, early detection, diagnosis, treatment critical, alongside prevention cross-infection, ensuring patient safety, controlling healthcare costs. To address these challenges, this review aims identify a comprehensive, rapid, safe, cost-effective diagnostic approach diseases. is framed within existing hierarchical system, focusing on establishing capabilities at hospitals, community, home levels effectively tackle above issues. In addition PCR isothermal amplification, also explores emerging molecular strategies that may better evolving needs disease diagnostics. A key focus transition from amplification technologies amplification-free biosensing approaches, particular attention given potential home-based testing. shift seeks overcome limitations conventional methods, in decentralized diagnostics, offering promising solution enhance speed safety future, integration AI into technologies, biosensors, various application levels, inclusively economic, safe diagnosis solutions will be further optimized, accessibility become widespread.
Язык: Английский
Процитировано
0
Biologicals, Год журнала: 2025, Номер 91, С. 101841 - 101841
Опубликована: Май 8, 2025
Язык: Английский
Процитировано
0